Edgewise Therapeutics Inc EWTX Q1 2026 Earnings Narrowerthanexpected loss underscores disciplined RD execution Day One Biopharmaceuticals DAWN Q4 2025 Earnings EPS Miss Reflects RD Spend Amid PreRevenue Status INVE Q1 2026 Earnings EPS Misses Estimates Revenue Not Disclosed SMR Q1 2026 Earnings WiderThanExpected Loss Amid PreRevenue Stage Stock Barely Moves BNZI Q1 2026 Earnings Substantial EPS Miss Sends Stock Lower CHDN Q1 2026 Earnings EPS Surges Past Estimates by 182